Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 424796, 8 pages
http://dx.doi.org/10.1155/2014/424796
Clinical Study

The Analysis of Genetic Aberrations in Children with Inherited Neurometabolic and Neurodevelopmental Disorders

1Department of Clinical and Experimental Neuropathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, Poland
2Department of Child Psychiatry, Medical University of Warsaw, 00-576 Warsaw, Poland
3GenCentrum (Regional Center for Clinical Genetics and Modern Technologies), 25-375 Kielce, Poland
4Department of Genetics, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland
5Department of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, Poland
6Department of Immunopathology of Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland
7Clinic of Child and Adolescent Neurology, Institute of Mother and Child, 01-211 Warsaw, Poland
8Department of Laboratory Diagnostics and Clinical Immunology, Medical University of Warsaw, 00-576 Warsaw, Poland

Received 28 February 2014; Revised 11 April 2014; Accepted 16 April 2014; Published 13 May 2014

Academic Editor: Ozgur Cogulu

Copyright © 2014 Krystyna Szymańska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Shevell, S. Ashwal, D. Donley et al., “Practice parameter: evaluation of the child with global developmental delay: report of the quality standards subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society,” Neurology, vol. 60, no. 3, pp. 367–380, 2003. View at Google Scholar · View at Scopus
  2. A. García-Cazorla, N. I. Wolf, M. Serrano et al., “Inborn errors of metabolism and motor disturbances in children,” Journal of Inherited Metabolic Disease, vol. 32, no. 5, pp. 618–629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. García-Cazorla, N. I. Wolf, M. Serrano et al., “Mental retardation and inborn errors of metabolism,” Journal of Inherited Metabolic Disease, vol. 32, no. 5, pp. 597–608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Trakadis and M. Shevell, “Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis,” Developmental Medicine and Child Neurology, vol. 53, no. 11, pp. 994–999, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. I. Shevell, B. A. Bejjani, M. Srour, E. A. Rorem, N. Hall, and L. G. Shaffer, “Array comparative genomic hybridization in global developmental delay,” American Journal of Medical Genetics, Part B, vol. 147, no. 7, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Stankiewicz, A. N. Pursley, and S. W. Cheung, “Challenges in clinical interpretation of microduplications detected by array CGH analysis,” American Journal of Medical Genetics, Part A, vol. 152, no. 5, pp. 1089–1100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. R. Schreck and C. M. Distèche, “Chromosome banding techniques,” in Current Protocols in Human Genetics, J. L. Haines, B. R. Korf, C. C. Morton et al., Eds., John Wiley & Sons, New York, NY, USA, 1994. View at Google Scholar
  8. L. J. Ozelius, J. W. Hewett, C. E. Page et al., “The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein,” Nature Genetics, vol. 17, no. 1, pp. 40–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Girirajan, Y. D. Megan, C. Baker et al., “Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder,” The American Journal of Human Genetics, vol. 92, no. 2, pp. 221–237, 2013. View at Publisher · View at Google Scholar
  10. S. J. Sanders, A. G. Ercan-Sencicek, V. Hus et al., “Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism,” Neuron, vol. 70, no. 5, pp. 863–885, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Zhang, R. Jia, L. Ying et al., “WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway,” Molecular Medicine Reports, vol. 6, no. 1, pp. 121–124, 2012. View at Google Scholar
  12. C.-P. Lo, L.-J. Hsu, M.-Y. Li et al., “MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1,” European Journal of Neuroscience, vol. 27, no. 7, pp. 1634–1646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Wende, S. G. Lechner, C. Cheret et al., “The transcription factor c-Maf controls touch receptor development and function,” Science, vol. 335, no. 6074, pp. 1373–1376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Hu, T. Huang, T. Li, Z. Guo, and L. Cheng, “C-Maf is required for the development of dorsal horn laminae III/IV neurons and mechanoreceptive DRG axon projections,” Journal of Neuroscience, vol. 32, no. 16, pp. 5362–5373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. F. Newbury, L. Winchester, L. Addis et al., “CMIP and ATP2C2 modulate phonological short-term memory in language impairment,” American Journal of Human Genetics, vol. 85, no. 2, pp. 264–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Szalontai and K. Csiszar, “Genetic insights into the functional elements of language,” Human Genetics, vol. 132, no. 9, pp. 959–986, 2013. View at Google Scholar
  17. S. H. Elsea and S. S. Girirajan, “Smith-Magenis syndrome,” European Journal of Human Genetics, vol. 16, no. 4, pp. 412–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. A. Nowakowska, E. Obersztyn, K. Szymańska et al., “Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C,” American Journal of Medical Genetics, Part B, vol. 153, no. 5, pp. 1042–1051, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Mayer, K. Botzel, W. Paulus, H. Plendl, D. Prockl, and A. Danek, “Movement-related cortical potentials in persistent mirror movements,” Electroencephalography and Clinical Neurophysiology, vol. 95, no. 5, pp. 350–358, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Lin, S. Shah, and R. F. Bulleit, “The expression of MEF2 genes is implicated in CNS neuronal differentiation,” Molecular Brain Research, vol. 42, no. 2, pp. 307–316, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Leifer, D. Krainc, Y.-T. Yu et al., “MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 4, pp. 1546–1550, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. A. C. Barbosa, M.-S. Kim, M. Ertunc et al., “MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 27, pp. 9391–9396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Hurst, M. Baraitser, E. Auger, F. Graham, and S. Norell, “An extended family with a dominantly inherited speech disorder,” Developmental Medicine and Child Neurology, vol. 32, no. 4, pp. 352–355, 1990. View at Google Scholar · View at Scopus
  24. E. Spiteri, G. Konopka, G. Coppola et al., “Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain,” American Journal of Human Genetics, vol. 81, no. 6, pp. 1144–1157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Segawa, “Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5),” Chang Gung Medical Journal, vol. 32, no. 1, pp. 1–11, 2009. View at Google Scholar · View at Scopus
  26. Y. Furukawa and S. J. Kish, “Dopa-responsive dystonia: recent advances and remaining issues to be addressed,” Movement Disorders, vol. 14, no. 5, pp. 709–715, 1999. View at Google Scholar
  27. K. Szymańska, A. Ługowska, M. Laure-Kamionowska et al., “Diagnostic difficulties in Krabbe disease: a report of two cases and review of literature,” Folia Neuropathologica, vol. 50, no. 4, pp. 346–356, 2012. View at Google Scholar
  28. R. Spiegel, G. Bach, V. Sury et al., “A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans,” Molecular Genetics and Metabolism, vol. 84, no. 2, pp. 160–166, 2005. View at Publisher · View at Google Scholar · View at Scopus